+467.0%
MRNA vs QSR
+28.6%
+438.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | QSR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.6% | +4.8% | +5.1% |
| 7D | -1.1% | -4.0% | +2.9% | +0.7% |
| 30D | +126.1% | +2.8% | +123.4% | +124.5% |
| 3M | +190.0% | +5.1% | +184.9% | +184.1% |
| 6M | +157.2% | +8.8% | +148.4% | +147.6% |
| YTD | +388.2% | +14.8% | +373.4% | +349.3% |
| 1Y | +467.0% | +25.7% | +441.3% | +373.6% |
| All | +467.0% | +28.6% | +438.4% | +373.6% |
Cumulative growth
Daily Returns
Daily percentage return beside QSR.
Daily Out/Under-Performance
Portfolio return minus QSR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × QSR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded QSR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling